Among the four biotech stocks that may be worth considering this month highlighted in today’s article is a company focused on developing genetic therapies with the potential to restore, improve and preserve high-acuity physiological hearing for people living with certain forms of disabling hearing loss. For more on this company and the other three biotech stocks featured, CLICK HERE.